The mainly DLG-owned Vitalys company located in Esbjerg has been sold to Glycom A/S. This was announced on January the 13th. This comes as part of DLG’s plans to sell off the parts of their business that are not essential to their core activities. Vitalys produced lysine, an amino acid used mainly in poultry and pig feed, and was the commercial partner in Project 4 investigating the large scale fermentation of 2G sugars to lysine. The lysine production has now halted and the factory will in the future focus on the production of human milk oligosaccharides (HMO) to be used in the production of formula for infants.
This means, however, that former CEO of Vitalys, Kjeld Kjeldsen has to withdraw as project manager for project 4 and DTU professor Peter Ruhdal Jensen will take over.
Conditions for continuation of Project 4 and potential adjustments in goals are being discussed with DLG and the BioValue board.